(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

X

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

X

ST13

US500000097792220

Class

42

Filing

97792220

Registration

7724865

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

28

Latest update

03/11/2025

Trademark type

Combined

Nice classes

42

Filing date

02/13/2023

Registration date

03/11/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/11/2025

Last transaction

03/11/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

03/31/2023

First use in commerce

03/31/2023

Drawing code

3

Owner type

03

Owner location

Knoxville, TN, US

Examiner

BELL, MARLENE

Law office

M90

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of a stylized letter "X" and design. The design consists of a circle and within the circle is a letter "X" formed by a stylized DNA helix symbol.

Holders and representatives

Holders

Helix Biotech, Inc

Representatives

Wade R. Orr Luedeka Neely, P.C.

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Chemical analysis; Chemical analysis services; Chemical research and analysis; Chemicalbiochemicalbiological and bacteriological research and analysis; Clinical research in the field of Lipid NanoparticlesLiposomesHybrid Nanoparticles; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Product development; Product development and engineering services for others; Product development consultation; Product development consulting in the field of Lipid Nanoparticles (LNPs) and Liposome Samples. LNP and Liposome FormulationManufacturingAnalytical Services; Product development for others; Product research and development; Consulting services for others in the field of designplanningimplementation project management of Lipid NanoparticlesLiposomesHybrid Nanoparticles; Consulting services in the field of product design and development; Design and testing for new product development; Executing of chemical analyses; Performance of chemical analyses; Providing medical and scientific research information in the field of pharmaceuticals; Providing reagent sample testing and diagnostic services for others for scientific research purposes

Publications

History of USPTO decisions and trademark events.

28 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

03/11/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

03/11/2025

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

02/19/2025

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

02/19/2025

SUPC

STATEMENT OF USE PROCESSING COMPLETE

02/13/2025

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

02/13/2025

IUAF

USE AMENDMENT FILED

12/03/2024

EISU

TEAS STATEMENT OF USE RECEIVED

12/03/2024

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

06/04/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/02/2024

PUBO

PUBLISHED FOR OPPOSITION

04/02/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/13/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/24/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/24/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/24/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/12/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/12/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/12/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

01/08/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

01/08/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

01/08/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

11/15/2023

GNRT

NON-FINAL ACTION E-MAILED

11/15/2023

CNRT

NON-FINAL ACTION WRITTEN

11/15/2023

DOCK

ASSIGNED TO EXAMINER

11/10/2023

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

03/03/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/02/2023

NWAP

NEW APPLICATION ENTERED

02/16/2023

Continuous trademark protection

Get notified about every new filing that threatens X or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.